News Ildong Pharmaceutical Co., Ltd.

Equities

A249420

KR7249420001

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
15,280 ^KRW	+1.39%		+1.73%	-15.86%

2023	Il Dong Pharmaceutical Eyes Approval for to Manufacture Japan's COVID-19 Treatment in South Korea	MT
2023	Il Dong Pharmaceutical Introduces New R&D Unit Yunovia	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Il Dong Pharmaceutical Eyes Approval for to Manufacture Japan's COVID-19 Treatment in South Korea	Dec. 29	MT
Il Dong Pharmaceutical Introduces New R&D Unit Yunovia	Nov. 06	MT
Ildong Pharmaceutical Co., Ltd. announced that it has received KRW 30 billion in funding	23-10-19	CI
Ildong Pharmaceutical Co., Ltd. announced that it expects to receive KRW 30 billion in funding	23-10-17	CI
Ildong Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
Il Dong's Application for Shionogi's COVID Oral Medication Accepted for Review in South Korea	23-01-04	MT
Ildong Pharmaceutical Co., Ltd. Files a New Drug Application with the MFDS for the Indication of SARS-CoV-2 Infection, and This Application Has Been Accepted for Review by MFDS	23-01-03	CI
Shionogi JV Sub-licenses COVID-19 Drug to South Korea's Il Dong Pharmaceutical	22-09-19	MT
Twist Bioscience, Ildong Pharmaceutical Partner to Discover Antibodies for Immuno-Oncology	22-06-30	MT
Twist Bioscience Corporation and Ildong Pharmaceutical Enter into Collaboration to Enhance Antibody Discovery for Applications in Immuno-Oncology	22-06-30	CI
Ildong Pharmaceutical : Interim Report on Business Performance (Fair Disclosure)	22-02-17	PU
South Korean Pharmaceutical Firms Rush to Develop COVID-19 Oral Pills	21-12-29	MT
Il Dong Pharmaceutical Starts Clinical Trial of COVID-19 Drug	21-11-29	MT
Ildong Pharmaceutical : starts Phase 1 study of new diabetes therapy in Germany	21-07-01	AQ
Ildong Pharmaceutical Starts Phase 1 Study of New Diabetes Therapy in Germany	21-07-01	CI
Ildong Pharmaceutical Co., Ltd. announced that it has received KRW 100 billion in funding	21-01-27	CI
Ildong Pharmaceutical Co., Ltd. announced that it expects to receive KRW 100 billion in funding	21-01-17	CI
Evotec SE and Ildong to Collaborate with Development Projects on Indigo Platform	20-03-31	CI
Ildong Pharmaceutical Co., Ltd. Enters into Co-Promotion Agreement with GSK Consumer Healthcare SA	19-12-04	CI
Ildong Holdings Co., Ltd. acquired 5.18% stake in Ildong Pharmaceutical Co., Ltd. from Il-dong Foods Co. Ltd. and Lee, Keumki for KRW 22.4 billion.	19-02-26	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Ildong Pharmaceutical Co., Ltd.

Equities

A249420

KR7249420001

Summary

Filters